ライフサイエンスコーパス: silicone oil

1 moving droplet in direct contact with heated silicone oil.

2 fluoride (SF6), 2.2% with air, and 0.4% with silicone oil.

3 d samples, most of the particles were due to silicone oil.

4 er's solution and the epithelium bathed with silicone oil.

5 lices in a tank filled with a high-viscosity silicone oil.

6 heavy silicone oil and conventional 'light' silicone oil.

7 ectomy with intravitreal injection of gas or silicone oil.

8 luid, and the outer surface was covered with silicone oil.

9 rcation, scleral buckle, and vitrectomy with silicone oil.

10 When silicone oil 200 cSt (SO200) was added to the systems, t

11 of these biologically active compounds into silicone oil, acting as lipophilic binder of glassy carb

12 with higher cataract risk (if repaired with silicone oil: adjusted hazard ratio [aHR], 10.37; 95% CI

13 icone oil endotamponade (DSOE) of both heavy silicone oil and conventional 'light' silicone oil.

14 Fibres were immersed in silicone oil and illuminated with 365 nm light.

15 go(ethylene glycol) to be solubilised within silicone oil and provide hydrogen bond acceptor sites to

16 s, and miscellaneous therapies (intravitreal silicone oil and TNF-alpha inhibitors).

17 model systems were studied: a polymer melt (silicone oil) and a molten (borosilicate) glass of compa

18 distinguish between buoyant particles (e.g., silicone oil) and dense particles (e.g., protein particl

19 luoride, 1.8% were with air, 17.9% were with silicone oil, and 10.7% were with cataract surgery.

20 propose a microscale gasometric assay using silicone oil as matrix.

21 An increase in intravitreal silicone oil associated with bevacizumab prepared with i

22 A new silicone oil-based tamponade was developed with a viscos

23 Viscosity and elasticity of various silicone oil blends (Siluron 1000, Siluron 2000, Siluron

24 ments with PVR, tamponade with either gas or silicone oil can be considered.

25 Short-term (14)C uptake (silicone oil centrifugation) and CO(2) release (membrane

26 Induction of the CCM, as measured by silicone oil centrifugation, was hindered in the presenc

27 ea (Pisum sativum) thylakoid membranes using silicone-oil centrifugation.

28 5 mum in the inner diameter) and a rotating, silicone oil-coated Teflon filter substrate at 1 rpm to

29 The incidence of silicone oil droplet injections was 0.03% (1 of 3230) fr

30 uble protein via protein adsorption onto the silicone oil droplet surface.

31 To determine the incidence of presumed silicone oil droplets after intravitreal bevacizumab was

32 R system can potentially distinguish between silicone oil droplets and protein particles in a size ra

33 injection had a higher risk of intravitreal silicone oil droplets compared with priming the syringe

34 on is further complicated by the presence of silicone oil droplets in solution.

35 of 60 patients who experienced intravitreal silicone oil droplets in the eye after intravitreal beva

36 ool for monitoring the effects of subvisible silicone oil droplets on the stability of protein formul

37 eneous protein aggregates due to exposure to silicone oil droplets, although oil droplets with surfac

38 emoval revealed RPE cells with intracellular silicone oil droplets, singly dispersed membrane-bound m

39 d protein from adsorbing onto the surface of silicone oil droplets.

40 serum albumin (BSA) aggregate particles and silicone oil emulsion droplets with adsorbed BSA.

41 Flow cytometric analyses revealed that silicone oil emulsions induced the loss of soluble prote

42 was also used to investigate the effects of silicone oil emulsions on the stability of BSA, lysozyme

43 ith pars plana vitrectomy (PPV) and a double silicone oil endotamponade (DSOE) of both heavy silicone

44 Double silicone oil endotamponade is a safe and effective treat

45 vitrectomy for retinal detachment and later silicone oil endotamponade owing to redetachment.

46 Further, polydimethylsiloxane silicone oil failed to serve as an adjuvant in the immun

47 e in eyes undergoing vitrectomy surgery with silicone oil for PVR.

48 0 patients requiring vitrectomy surgery with silicone oil for retinal detachment with established PVR

49 difficult to differentiate microdroplets of silicone oil from particles formed by aggregated protein

50 Postoperative complications included silicone oil in a deep anterior chamber (3 eyes in each

51 nor S-nitroso-acetylpenicillamine (SNAP) and silicone oil in commercial medical grade silicone rubber

52 ilure rate between tamponade with gas versus silicone oil in patients with grade B or C-1 PVR.

53 actors, large retinal lesion size and use of silicone oil in retinal detachment repair are potentiall

54 % underwent further RD surgery, and 8.3% had silicone oil in situ at last review.

55 investigate droplet dynamics in concentrated silicone oil-in-water nanoemulsions using light scatteri

56 oach to cell sheet release surfaces based on silicone oil-infused polydimethylsiloxane.

57 rcation as an alternative to vitrectomy with silicone oil injection in macula-sparing cytomegalovirus

58 s with medically uncontrolled glaucoma after silicone oil injection may require oil removal with or w

59 last patient had a pars plana vitrectomy and silicone oil instillation combined with phacoemulsificat

60 y centrifugation of cells through a layer of silicone oil into a denser solution of trichloroacetic a

61 or migration of emulsified or nonemulsified silicone oil into the anterior chamber.

62 Injecting 50 mm KCl or silicone oil into the intercellular spaces also caused s

63 optimum surgery was the injection of liquid silicone oil into the vitreous cavity to dissect fibrous

64 side of the eye; however, drug solubility in silicone oil is poor and release from this hydrophobic d

65 Additionally, as silicone oil-lubricated prefilled syringes become a favo

66 findings underscore that direct contact with silicone oil may affect the behavior of the RPE, which m

67 in protein aggregates and is contaminated by silicone oil microdroplets.

68 ecture and composition to play a role in the silicone oil miscibility of the targeted polymers.

69 The insertion of silicone oil offers the opportunity to also deliver drug

70 f small sample volumes that uses layering of silicone oil on solution surfaces but still allows the u

71 o the vitreous cavity; the direct effects of silicone oil on the RPE are only beginning to be underst

72 The device is equipped to use either silicone oil or coconut oil.

73 t the release of all-trans retinoic from the silicone oil phase was extended to >72days.

74 atogenous retinal detachment (RRD) (n = 17), silicone oil removal (n = 16), dislocated intraocular le

75 retinal proliferations peeled at the time of silicone oil removal revealed RPE cells with intracellul

76 anatomical success (retinal attachment after silicone oil removal) was achieved in 20 (83.3%) eyes at

77 At the time of silicone oil removal, the pigmented membranes were prese

78 t the time of (1) vitrectomy surgery and (2) silicone oil removal.

79 cities (n = 8), endophthalmitis (n = 4), sub-silicone oil retinal detachment (n = 3), retained lens m

80 can develop after intravitreal injection of silicone oil secondary to pupillary block, inflammation,

81 acoemulsification with IOL implant, PPV with silicone oil tamponade associated with 180 degrees infer

82 All patients subsequently underwent PPV and silicone oil tamponade at our Institution.

83 rectomy, 180 degrees inferior retinotomy and silicone oil tamponade combined with phacoemulsification

84 an intravitreal tamponade, one patient with silicone oil tamponade developed band keratopathy and ph

85 undergone large relaxing retinectomies with silicone oil tamponade for PVR-related retinal detachmen

86 lowing vitrectomy surgery with endolaser and silicone oil tamponade for retinal detachment.

87 Silicone oil tamponade is more frequently reserved for c

88 Silicone oil tamponade should be considered in patients

89 s undergoing pars plana vitrectomy (PPV) and silicone oil tamponade with or without scleral buckling

90 ternal limiting membrane peeling, and gas or silicone oil tamponade.

91 group required a third vitrectomy with heavy silicone oil tamponade.

92 s humour within the eye and replacement with silicone oil to aid healing of the retina.

93 f TTR105-115 amyloid fibrils in water and in silicone oil to be 2.6 and 8.1 GPa, respectively.

94 cated by formulation components, such as the silicone oil used for the lubrication of prefilled syrin

95 fibres from rabbit psoas muscle immersed in silicone oil was measured using a linked enzyme assay th

96 etected in 12 (33.3 %) patients in which the silicone oil was used as an intravitreal tamponade, one

97 takes place at the triple interface between silicone oil, water, and a penetrating solder-patterned

98 droplet generation (FC-70 Fluorinert oil and silicone oil) were also tested against the different sol

99 micron-sized droplets of water surrounded by silicone oil where each microdroplet contains <1 enzyme

100 The bundles were then transferred to silicone oil, where [Ca2+]free, tension, and sarcomere l

101 of flow cytometry were exploited by staining silicone oil with BODIPY 493/503 and model proteins with

102 speed of a helix in a high-molecular weight silicone oil with predictions for the swimming speed in

103 stable retinal reattachment with removal of silicone oil without additional vitreoretinal surgical i